Results 81 to 90 of about 2,738 (166)

Lipoprotein apheresis: a Hellenic consensus on its clinical use

open access: yesHellenic Journal of Cardiology, 2021
Genovefa Kolovou   +16 more
doaj   +1 more source

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection

open access: yesMedical Devices: Evidence and Research, 2016
Ulrich Julius Lipidology and Center for Extracorporeal Therapy, Department for Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany Abstract: This review reports the current situation ...
Julius U
doaj  

[Low density lipoprotein apheresis].

open access: yesMedicina (Kaunas, Lithuania), 2004
Increased blood cholesterol concentration is one of the main factors in ischemic heart disease, development of which is determined by atherosclerotic changes in coronary vessels. Diet and treatment with 3-hydroxi-3-metilglutaril coenzyme A (HMG-CoA) reductase inhibitors helps to reduce low density lipoprotein cholesterol (LDL-Ch) blood concentration up
Remigijus, Zaliūnas   +4 more
openaire   +1 more source

Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey. [PDF]

open access: yesOrphanet J Rare Dis, 2021
D'Erasmo L   +34 more
europepmc   +1 more source

COVID-19 swab collection and serological screening in lipoprotein apheresis unit. [PDF]

open access: yesJ Clin Apher, 2020
Sbrana F   +5 more
europepmc   +1 more source

Lipoprotein(a) apheresis restores coronary microcirculation in refractory angina

open access: yesRevista Portuguesa de Cardiologia, 2022
Francesco Sbrana   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy